To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for mifepristone, and for other purposes.

H.R. 3935 The Securing Growth and Robust Leadership in American Aviation Act Title II-General Aviation; Subtitle C-Improving FAA Services; Sec. 245. National coordination and oversight of designated pilot examiners. Sec. 247. Designee Locator Tool Improvements. Subtitle D-Other Provisions; Sec. 262. Supplemental oxygen regulatory reform. Title III-Aerospace Workforce; Section 301. Extension of aviation workforce development programs. Sec. 302. Improving aviation workforce development programs. Subtitle C-Engaging and Retaining the Workforce. Sec. 328. Aeromedical innovation and modernization working group. Title V-Aviation Safety; Section 524. Part 135 Duty and Rest. S. 1939 FAA Reauthorization Act of 2023 Title III-Safety Improvements Sec. 341 Part 135 pilot supplemental oxygen requirement Title V-Aviation Workforce; Subtitle A-Civil Aviation Workforce, Section 501. Aviation workforce development grants. Section 509. Aviation Medical Innovation and Modernization Working Group. H.R. 1818 Aviation Workforce Development Act-Expands the qualified tuition program (529 Plans) to certain aviation maintenance and commercial pilot courses. H.R. 5850 Continuing Appropriations Act 2024 and Other Extensions Act Title II-FAA Extension Other Issues: Part 135 Pilot Rest and Duty Rules Part 135 Ferry Flight Restrictions FAA AeroMedicalAerospace Medicine Reforms/Special Medical Issuances 1500 Hour Pilot Flight Training Requirements Sustainable Aviation Fuels (SAF) Aviation Workforce Business Aviation